333 related articles for article (PubMed ID: 19220753)
41. [Levosulpiride in the management of functional dyspepsia and delayed gastric emptying].
Serra J
Gastroenterol Hepatol; 2010 Oct; 33(8):586-90. PubMed ID: 20850200
[TBL] [Abstract][Full Text] [Related]
42. Gastroduodenal motility disorders.
Tack J; Van den Houte K; Carbone F
Curr Opin Gastroenterol; 2018 Nov; 34(6):428-435. PubMed ID: 30199408
[TBL] [Abstract][Full Text] [Related]
43. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters.
Haag S; Talley NJ; Holtmann G
Gut; 2004 Oct; 53(10):1445-51. PubMed ID: 15361493
[TBL] [Abstract][Full Text] [Related]
44. Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients.
Futagami S; Yamawaki H; Izumi N; Shimpuku M; Kodaka Y; Wakabayashi T; Nagoya H; Shindo T; Kawagoe T; Gudis K; Itoh T; Sakamoto C
J Gastroenterol Hepatol; 2013 Aug; 28(8):1314-20. PubMed ID: 23611167
[TBL] [Abstract][Full Text] [Related]
45. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
[TBL] [Abstract][Full Text] [Related]
46. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
[TBL] [Abstract][Full Text] [Related]
47. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test.
Lee JS; Camilleri M; Zinsmeister AR; Burton DD; Choi MG; Nair KS; Verlinden M
Am J Gastroenterol; 2000 Oct; 95(10):2751-61. PubMed ID: 11051344
[TBL] [Abstract][Full Text] [Related]
48. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).
Melzer J; Rösch W; Reichling J; Brignoli R; Saller R
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1279-87. PubMed ID: 15606389
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
50. The Effect of Continuous Intake of
Ohtsu T; Haruma K; Ide Y; Takagi A
Nutrients; 2021 May; 13(6):. PubMed ID: 34071718
[TBL] [Abstract][Full Text] [Related]
51. Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence.
Goelen N; Jones M; Huang IH; Carbone F; Janssen P; Tack J
United European Gastroenterol J; 2023 Mar; 11(2):146-162. PubMed ID: 36714973
[TBL] [Abstract][Full Text] [Related]
52. Erythromycin promotes gastric emptying during acute pain in volunteers.
Bouvet L; Duflo F; Bleyzac N; Mion F; Boselli E; Allaouchiche B; Chassard D
Anesth Analg; 2006 Jun; 102(6):1803-8. PubMed ID: 16717329
[TBL] [Abstract][Full Text] [Related]
53. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying.
Song CW; Chun HJ; Kim CD; Ryu HS; Choe JG; Hyun JH
Korean J Intern Med; 1998 Feb; 13(1):15-21. PubMed ID: 9538626
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia.
Kusunoki H; Haruma K; Hata J; Ishii M; Kamada T; Yamashita N; Honda K; Inoue K; Imamura H; Manabe N; Shiotani A; Tsunoda T
Intern Med; 2010; 49(20):2195-202. PubMed ID: 20962437
[TBL] [Abstract][Full Text] [Related]
55. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
[TBL] [Abstract][Full Text] [Related]
56. [Non-invasive 13C octanoic acid breath test for measuring stomach emptying of a solid test meal--correlation with scintigraphy in diabetic patients and reproducibility in healthy probands].
Pfaffenbach B; Wegener M; Adamek RJ; Wissuwa H; Schaffstein J; Aygen S; Hennemann O
Z Gastroenterol; 1995 Mar; 33(3):141-5. PubMed ID: 7754644
[TBL] [Abstract][Full Text] [Related]
57. Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.
Schemann M; Michel K; Zeller F; Hohenester B; Rühl A
Phytomedicine; 2006; 13 Suppl 5():90-9. PubMed ID: 16765572
[TBL] [Abstract][Full Text] [Related]
58. Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores.
Lacy BE; Everhart K; Crowell MD
Dig Dis Sci; 2019 May; 64(5):1281-1287. PubMed ID: 30382539
[TBL] [Abstract][Full Text] [Related]
59. Prokinetics in patients with gastroparesis: a systematic analysis.
Sturm A; Holtmann G; Goebell H; Gerken G
Digestion; 1999; 60(5):422-7. PubMed ID: 10473966
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
